Whats new

Whats new.

Canaccord Genuity - Efti continues to impress in CPS<1 HNSCC patients; Maintain Buy, A$0.95 PT (Analyst: Elyse Shapiro)

July 12th 2024

For a copy of this research report please contact your Canaccord Genuity advisor